Hello and welcome to the details of AstraZeneca to supply 500,000 more Covid-19 antibody cocktail to US and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
WASHINGTON, March 16 ― AstraZeneca said today it has agreed to supply up to half a million additional doses of its experimental antibody-based Covid-19 combination treatment to the United States for US$205 million (RM843.5 million).
In October, the Anglo-Swedish drugmaker and US government agencies had initially agreed for a supply of 200,000 doses. The extension brings potential US supplies of the treatment to 700,000 doses and the total value of the deal to US$726 million.
The treatment, AZD7442, is a combination of two monoclonal antibodies and has not been approved for use as yet, AstraZeneca said, adding that the new agreement is contingent on an approval by the US Food and Drug Administration.
The company said it does not expect any changes to its 2021 forecasts because of the deal. ― Reuters
These were the details of the news AstraZeneca to supply 500,000 more Covid-19 antibody cocktail to US for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.